Approvals for MDMA-Assisted PTSD Therapy: What's the Timeline?

MDMA-Assisted Therapy for PTSD Edges Toward Acceptance – When Might It Be Approved?

,
The FDA will have 60 days "to determine whether the MDMA-AT NDA application will be accepted for review and whether it will be a priority or standard review. The estimate timeline is six months or ten months.
Why Do Magic Mushrooms Bruise Blue? Mystery Solved

Why Do Magic Mushrooms Bruise Blue? Mystery Solved

The blue coloration of magic mushrooms is a chemical reaction triggered by damage or stress. This process, similar to how an apple turns brown when cut, is due to the oxidation of psilocybin, the psychoactive compound in these mushrooms.
Why Do We See So Much Clearer on Low Doses of Psychedelics?

Why Do We Feel Like We Can Score 40/20 in Visual Acuity on Low Doses of Psychedelics?

,
One possible reason for this phenomenon is psilocybin’s interaction with the thalamus, the section of our brain that receives sensory information and relays it to different brain areas for processing.
Psychedelic Holiday Gift Guide 2023: 11 Ideas for Your Favorite Soul Seekers

Psychedelic Holiday Gift Guide 2023: 11 Ideas for Your Favorite Soul Seekers

This year's holiday gift guide celebrates psychedelics and nods to those who appreciate the profound and the extraordinary.
5 Legal Ways to Explore Psychedelic Experiences

5 Legal Ways to Explore Psychedelic Experiences

,
Delving into 5 legal ways to explore psychedelic experiences, and the potential risks of using these hallucinogenic substances.
The Biggest Psychedelic News This Week: November 27th - December 1st

The Biggest Psychedelic News This Week: November 27th – December 1st

,
The evidence pile for psilocybin’s efficacy in treating depression is growing with new data demonstrating 79% remission rates after two doses. Meanwhile, early trials hint at MEAI’s efficacy in treating obesity, ketamine studies suggest a single dose is effective in treating anxiety and discussions arise about psychedelic use and its capacity to birth new environmentalists.
psychedelics as the new painkillers

New Study Says LSD and Psilocybin Could Outperform Opioids for Pain, Without Developing Tolerance

Classic psychedelics might effectively kill pain with even greater vigor over time, sharply contrasting with opioids.
Tidal Wave Mushrooms: The Complete Guide

Tidal Wave Mushrooms: A Guide to One of the Most Potent Varieties Ever Tested

,
Tidal Wave mushrooms have made a splash in the psychedelic community since their creation, and for good reason. This hybrid strain, created by Magic Myco and winner of the inaugural Psilocybin Cup, wowed users due to its unprecedented potency.
The Biggest Psychedelic News This Week: November 20th-24th

The Biggest Psychedelic News This Week: November 20th-24th

,
Psilocybin use shows reduced psychological distress in individuals with adverse childhood experiences, while microdosing shows a "both and" approach to treating ADHD.
Microdosing for ADHD

Stacking Psychedelic Microdoses with ADHD Medication? New Study Hints “Both And” Could Work

A new study exploring real-world psychedelic microdosing for ADHD could help reimagine the way we perceive and treat the condition.